ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-pxv.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-pxv.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-pxxxiii.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-pxxxiii.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p567.xmlContinuing the Conversation: Questions on Cancer Care from the NCCN Annual Conference2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p567.pdf2026-04-18Continuing the Conversation: Questions on Cancer Care from the NCCN Annual Conferencehttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p589.xmlHodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p589.pdf2026-04-18Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelineshttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p577.xmlA Case of Diffuse Large B-Cell Lymphoma in Association With Paraesophageal Leiomyoma: Highlighting False-Positivity of PET Scan and Importance of Tissue Diagnosis2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p577.pdf2026-04-18A Case of Diffuse Large B-Cell Lymphoma in Association With Paraesophageal Leiomyoma: Highlighting False-Positivity of PET Scan and Importance of Tissue Diagnosishttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p584.xmlWhere is the EHR in Oncology?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p584.pdf2026-04-18Where is the EHR in Oncology?https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p574.xmlTen Years of Progress in Colon Cancer Therapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p574.pdf2026-04-18Ten Years of Progress in Colon Cancer Therapyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p628.xmlCancer- and Chemotherapy-Induced Anemia2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p628.pdf2026-04-18Cancer- and Chemotherapy-Induced Anemiahttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p678.xmlMeasuring the Evidence That Informs Clinical Treatment Recommendations2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p678.pdf2026-04-18Measuring the Evidence That Informs Clinical Treatment Recommendationshttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p599.xmlThe Management of Patients With Stage IIIA Non–Small Cell Lung Cancer With N2 Mediastinal Node Involvement2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p599.pdf2026-04-18The Management of Patients With Stage IIIA Non–Small Cell Lung Cancer With N2 Mediastinal Node Involvementhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p669.xmlTotal Dose Iron Dextran Infusion in Cancer Patients: Is it SaFe2+?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p669.pdf2026-04-18Total Dose Iron Dextran Infusion in Cancer Patients: Is it SaFe2+?https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p659.xmlUpdate on Safety of ESAs in Cancer-Induced Anemia2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p659.pdf2026-04-18Update on Safety of ESAs in Cancer-Induced Anemiahttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p618.xmlOral Chemotherapy Program Improves Adherence and Reduces Medication Wastage and Hospital Admissions2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/5/article-p618.pdf2026-04-18Oral Chemotherapy Program Improves Adherence and Reduces Medication Wastage and Hospital Admissions